Friday, July 20, 2018 9:56:15 AM
Definitely not a competitor. Actually this company and all blood glucose test and data companies would want to contract with ALRT to integrate with the ALRT platform. I think this is partly why we are not seeing any new stock buyers. Most people don't understand that ALRT is a platform that accumulates the data for providers and insurers and allows for remote care plan decision making guidance on medications, on patient adherence, on insulin guidance, A1c prediction, etc. Allowing for remote management of large scale populations and allowing for those with diabetes to be placed on the proper care plan is key to improving outcome and reducing cost.
Recent ALRTF News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/05/2026 06:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/30/2025 06:49:39 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/30/2025 06:38:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/07/2025 09:10:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/26/2025 05:31:37 PM
- Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/02/2025 05:45:54 PM
- Form NT 20-F - Notification of inability to timely file Form 20-F • Edgar (US Regulatory) • 05/01/2025 05:48:37 PM
